Dietary Intake of Alpha-linolenic Acid in Elderly
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jan 18, 2017
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
There is growing evidence that diets high in long chain n-3 polyunsaturated fatty acids (PUFA) decrease the risk of fatal ischemic heart disease.Both epidemiologic studies and clinical trials demonstrate substantial cardioprotective effects of alpha linolenic acid (ALA) from vegetable oils.However, little is known about the relation of the dietary intake of ALA with ischemic heart disease among older adults.In this study, elderly volunteers will be asked to ingest a supplement of a vegetable oil providing 1g of ALA, or an equivalent amount of linoleic acid as sunflower oil, for a diet perio...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Elderly patients over 65 years old exhibiting clinical indices of cardiovascular disease
- • Male or female
- • Subjects who were hospitalized in the Geriatric Unit of the Emile Roux Hospital (AP-HP)
- • MMSE (Mini Mental State Examination)score \> or = 15
- • Supervision available for study medication
- • Able to ingest oral diet
- Exclusion Criteria:
- • Patients unable to understand the objectives of the dietary intervention
- • Patients in paliative care
- • Patients receiving supplement diets
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Limeil Brevannes, , France
Patients applied
Trial Officials
olivier henry, MD
Principal Investigator
Assistance Publique de Paris. Hopital Emile Roux
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials